CX3CL1/Fractalkine Chemokine Domain Protein 362-CX-025/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCX3CL1/Fractalkine Chemokine Domain Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $415.00Supplier Page View Company Product Page
Catalog Number362-CX-025/CF
SpeciesHuman
Molecule NameCX3CL1/Fractalkine
Size25 ug
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human CX3CL1/Fractalkine (Chemokine Domain), CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene NameC-X3-C motif chemokine ligand 1
NCBI Gene AliasesABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin

Available conjugates: Sizes Available: 25 ug

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) The homozygous CX3CR1-M280 mutation impairs human monocyte survivalJCI insightFebruary 8, 2018Collar AL, Swamydas M, O'Hayre M, Sajib MS, Hoffman KW, Singh SP, Mourad A, Johnson MD, Ferre EM, Farber JM, et al.

(2) Fractalkine induces angiogenic potential in CX3CR1-expressing monocytesJournal of leukocyte biologyJanuary 1, 2018Park Y, Lee J, Kwak JY, Noh K, Yim E, Kim HK, Kim YJ, Broxmeyer HE, Kim JA.

(3) Plasmodium falciparum proteins involved in cytoadherence of infected erythrocytes to chemokine CX3CL1Scientific reportsSeptember 22, 2016Hermand P, Cicéron L, Pionneau C, Vaquero C, Combadière C, Deterre P.

(4) CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisBloodDecember 15, 2008Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, Melville L, Melrose LA, Ogden CA, Nibbs R, et al.

(5) Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviourJournal of neurochemistryJuly 1, 2008Holmes FE, Arnott N, Vanderplank P, Kerr NC, Longbrake EE, Popovich PG, Imai T, Combadière C, Murphy PM, Wynick D.

(6) Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences of the United States of AmericaJune 19, 2007Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F, Dehvari M, Wotherspoon G, Winter J, Ullah J, et al.

(8) Immunohistochemical assessment of fractalkine, inflammatory cells, and human herpesvirus 7 in human salivary glandsThe journal of histochemistry and cytochemistry : official journal of the Histochemistry SocietyMay 1, 2004Latchney LR, Fallon MA, Culp DJ, Gelbard HA, Dewhurst S.

(9) The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivoThe American journal of pathologyMarch 1, 2001Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, Powrie F, Greaves DR.

CX3CL1/Fractalkine Chemokine Domain Protein from R&D Systems, a Bio-Techne Brand